.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
UBS
Federal Trade Commission
Fuji
Baxter
Moodys
AstraZeneca
Merck
Accenture
Johnson and Johnson

Generated: June 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: fosaprepitant dimeglumine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck And Co Inc
EMEND
fosaprepitant dimeglumine
POWDER;INTRAVENOUS022023NDAMerck Sharp & Dohme Corp.0006-3061-001 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)
Merck And Co Inc
EMEND
fosaprepitant dimeglumine
POWDER;INTRAVENOUS022023NDAMerck Sharp & Dohme Corp.0006-3941-321 VIAL, SINGLE-DOSE in 1 CARTON (0006-3941-32) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3941-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Fish and Richardson
Argus Health
Cantor Fitzgerald
Merck
Teva
UBS
Deloitte

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot